Supplementary Table S3 from Anagrelide for Gastrointestinal Stromal Tumor
Year: 2023
Type: supplementary-materials
Abstract: Supplementary Table S3. Comprehensive drug sensitivity and resistance testing with 200 cancer drugs. Cell viability in GIST882 and GIST48 cell lines was measured in five different concentrations over a 10,000-fold concentration range.
Authors: Olli-Pekka Pulkka, Yemarshet K. Gebreyohannes, Agnieszka Wozniak, John-Patrick Mpindi, Olli Tynninen, Katherine Icay, Alejandra Cervera, Salla Keskitalo, Astrid Murumägi, Evgeny Kulesskiy, Maria Laaksonen, Krister Wennerberg, Markku Varjosalo, Pirjo Laakkonen, Rainer Lehtonen, Sampsa Hautaniemi, Olli Kallioniemi, Patrick Schöffski, Harri Sihto, Heikki Joensuu
Language: English
Subfield: Gastroenterology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4361935243